Private Company Director

Mastering the Board CEO Relationship


News and Articles

Black directors have formed an organization focusing on healthcare inequities in Black communities.
Eight private company boards will be honored at the 2023 Private Company Governance Summit.
Independent board directors offer experience, perspective and knowledge during a challenging economy.
A new Deloitte report sees directors increasingly focused on workplace issues and climate change.
Some of directors’ most impactful time is spent in interim meetings, one-off calls and dinners
A successful onboarding of the chief executive depends on communication, shareholder relationships and effective coaching.
This most important governance relationship is more complex for a private company.
Sometimes the easiest way to divine top boardroom concerns is to read the financial news. Or you can always ask your directors!
The process of letting the chief executive go is made easier when the directors keep the best interest of the company in mind.

US Foods Announces Changes to Board of Directors

US Foods Holding Corp. announced that Timothy R. McLevish has resigned effective immediately from his position on the Board of Directors after it was announced that he will become the Executive Chairman of Lamb Weston Holdings, Inc. Because Lamb Weston is a significant supplier to US Foods, McLevish would no longer qualify as an independent director.

John J. Brennan Elected Chairman of FINRA Board of Governors

The Financial Industry Regulatory Authority (FINRA) Board of Governors unanimously elected John J. “Jack” Brennan, Vanguard Group Chairman Emeritus and Senior Advisor, as FINRA Chairman effective Aug 15, 2016.

Brennan has served as FINRA’s Lead Governor since 2011 and succeeds Richard G. Ketchum as Chairman. His term will be effective upon Ketchum’s previously announced retirement.

Read the full press release here.

Dr. Cheryl Pegus Named to US Acute Care Solutions Board of Directors

Submitted by RChakler on Mon, 07/18/2016 - 16:55

US Acute Care Solutions (USACS) today announced Cheryl Pegus MD, MPH, has joined the company’s board of directors.

Pegus has served as the Chief Medical Officer for Walgreens and the Chief Medical Officer for SymCare. Prior to that, she held positions of increasing medical and professional responsibility at Aetna, LipoScience and Pfizer. Dr. Pegus currently serves as the Director of the Division of General Internal Medicine and Clinical Innovation at New York University School of Medicine.

DuPont Veteran, Jim Borel, Joins the Board of Directors at Farmers Edge

Submitted by RChakler on Fri, 07/01/2016 - 15:03

Farmers Edge, a global leader in precision agriculture and independent data management solutions, announced that Jim Borel, a recently retired Executive Vice President of DuPont, has joined its Board of Directors.

Widely considered one of the most influential and experienced figures in global agriculture, Borel joins existing board members Steve Mills of Archer Daniels Midland Company and Dayna Spiring, former chief strategy officer of the Canadian Wheat Board, during a period of rapid growth for the company.

The Secret to Finding Capital For Your Business

[[{"fid":"431","view_mode":"default","fields":{"format":"default","field_file_image_alt_text[und][0][value]":"","field_file_image_title_text[und][0][value]":""},"type":"media","link_text":null,"attributes":{"height":150,"width":100,"style":"width: 100px; height: 150px; float: right;","class":"media-element file-default"}}]]Are you seeking capital to fund growth or innovation plans for your family business? I can tell you where to get cash -- and get it instantly. There’s no paperwork to complete, and you don’t need to present your business plan to anyone.


Vizient, Inc. Announces New Members to its Board of Directors

Submitted by RChakler on Tue, 06/28/2016 - 14:21

Vizient, Inc., the largest member-driven health care performance company in the country, announced that its board of directors has appointed three new members.

Ralph W. Muller, chief executive officer of the University of Pennsylvania Health System; C.A. Lance Piccolo, president and chief executive officer of HealthPic; and Carol J. Zierhoffer, senior vice president and global chief information officer for Bechtel Corporation, have been appointed to the Vizient board, effective immediately.

Opus Bank Announces Appointment of Tom Bowers to Its Board of Directors

Submitted by RChakler on Tue, 06/28/2016 - 14:19

Opus Bank announced that Tom Bowers, Chief Operating Officer of Starwood Capital Group, has been appointed to the Opus’ Board of Directors, effective June 23, 2016.

He was also appointed a member of the Compensation Committee and Nominating and Corporate Governance Committee. Bowers replaces Marcos Alvarado, formerly Senior Vice President and Managing Director of Starwood Capital Group, who concurrently resigned from Opus’ Board of Directors, effective June 23, 2016. Opus’ board membership remains at nine.

Millendo Therapeutics Appoints New Independent Board Member and Names Chairperson of the Board

Submitted by RChakler on Fri, 06/24/2016 - 14:08

Millendo Therapeutics, Inc., a company developing novel therapies for endocrine diseases caused by hormone dysregulation, announced the appointment of James Hindman as an independent board member and chairperson of its audit committee. In addition, Millendo has appointed current board member and Partner of New Enterprise Associates, Inc., Carol Gallagher, Pharm.D., as Chairperson of the Board.

TARA Biosystems Appoints Biotechnology Pioneer Robert Langer, Ph.D., to Board of Directors

Submitted by RChakler on Thu, 06/23/2016 - 17:05

TARA Biosystems, Inc., a company developing physiologically relevant “heart-on-a-chip” tissue models for both toxicology and drug discovery applications, announced that it has appointed biotechnology entrepreneur, scientist and engineer Robert S. Langer, Ph.D., to its board of directors.

Langer is the David H. Koch Institute Professor at MIT. A founder of more than 30 life science companies and the most cited engineer in the world, Dr. Langer’s patents have been licensed or sublicensed to more than 300 pharmaceutical, chemical, biotechnology and medical device companies.

Directors Record